COMMUNIQUÉS West-GlobeNewswire

Eyenovia’s EYN PG21 Trial Evaluating High-Precision Microdose of Latanoprost Demonstrates Robust Intraocular Pressure Lowering and Patient Usability
13/08/2018
Positive results validate Eyenovia’s piezo-print technology for topical eye treatment as Company prepares for Phase III trials in progressive myopia, CACG and mydriasis NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- [...]
VistaGen Therapeutics and Baylor College of Medicine Collaborate on First-Step Study to Test VistaGen’s AV-101 for Potential Anti-Suicidal Effects in Veterans
13/08/2018
Veterans from Operation Enduring Freedom, Operation Iraqi Freedom and Operation New Dawn to Participate in Study SOUTH SAN FRANCISCO, Calif. and HOUSTON, Aug. 13, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. ( [...]
Pure Global Cannabis, Inc. Uniquely Positioned to Lead Cannabis Health & Wellness Market-- CFN Media
13/08/2018
SEATTLE, WA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article [...]
Hemispherx Updates Stockholders, Highlighting Ampligen’s Role in Enhancing Immunotherapeutic Therapies
13/08/2018
OCALA, Fla., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, is pleased to [...]
AIT Therapeutics Announces $20 Million Common Stock Purchase Agreement with Institutional Investor, Lincoln Park Capital Fund
13/08/2018
GARDEN CITY, N.Y., and REHOVOT, Israel, Aug. 13, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB) (“AIT Therapeutics or the “Company”), a clinical-stage medical device and biopharmaceutical company focused on [...]
Arbutus’ LNP Licensee Alnylam Announces FDA Approval of ONPATTRO™ (patisiran), for the Treatment of ATTR Amyloidosis
13/08/2018
ONPATTRO Approval Triggers Royalty to Arbutus Clinically Validated LNP Technology Now in the Hands of Genevant to Develop RNA-based Products WARMINSTER, Pa., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma [...]
First Choice Healthcare Solutions to Host Second Quarter 2018 Results Conference Call on August 15, 2018
13/08/2018
MELBOURNE, Fla., Aug. 13, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB: FCHS ) ("First Choice" or the "Company"), a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 10 August 2018
13/08/2018
Bagsværd, Denmark, 13 August 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article [...]
Transactions under Novozymes’ stock buyback program
13/08/2018
Please read the full announcement in the attached PDF Attachment 2018_48_Stock_Buybackprogram_EN
Allscripts Payerpath™ Achieves EHNAC Healthcare Network Accreditations
13/08/2018
Both HNAP and APAP accreditations ensure adherence to health data processing standards and compliance with security infrastructure and integrity requirements CHICAGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ [...]
CTD Holdings Announces Expanded Access Protocol using Intravenous Trappsol® Cyclo™ for Alzheimer’s Disease
13/08/2018
Protocol Available on ClinicalTrials.gov ALACHUA, Fla., Aug. 13, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the [...]
Sun BioPharma, Inc. Provides a Business Update and Files Report for Q2 2018
13/08/2018
First Patients Enrolled in Front-Line Combination Study of SBP-101 with Gemcitabine and nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer Additional Funds Raised during Q2 MINNEAPOLIS, Aug. 13, 2018 ( [...]
HealthEC Launches Opioid Analytics Module at 2018 MESC Conference
13/08/2018
New solution tackles key opioid-addiction issues state Medicaid agencies will be addressing at Medicaid Enterprise Systems Conference EDISON, N.J., Aug. 13, 2018 (GLOBE NEWSWIRE) -- HealthEC , a KLAS-recognized end-to- [...]
Catalyst Biosciences Announces Oral Presentation at the 2018 Hemophilia Drug Development Summit
13/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
Arsanis Reports Financial Results for Second Quarter 2018
13/08/2018
WALTHAM, Mass. and VIENNA, Austria, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Arsanis, Inc. (NASDAQ: ASNS), a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address [...]
BioSig Technologies Completes Private Placement
13/08/2018
Capital Raised to Support Nasdaq Uplist and Commercial Launch Santa Monica, CA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical [...]
Mustang Bio and St. Jude Children’s Research Hospital Enter into Exclusive Worldwide License Agreement for a Ground-Breaking, Clinical-Stage Lentiviral Gene Therapy with Curative Potential for X-linked Severe Combined Immunodeficiency
13/08/2018
Mustang Expands Pipeline into Gene Therapy for Rare Disease NEW YORK and MEMPHIS, Tenn., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a Fortress Biotech (NASDAQ: FBIO) Company focused [...]
Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer
13/08/2018
NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Xeris Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Highlights
13/08/2018
Successfully Completed Initial Public Offering (IPO) Submitted New Drug Application (NDA) for Glucagon Rescue Pen CHICAGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty [...]

Pages